For over 20 years, Avi Veidman served in the Israeli intelligence forces, and he used AI to to map the world. In the military he used AI for national defense, and he learned its power.

He then realized that just as AI could map a battlefield, it could map cancer cells in biopsies and pathology slides.

Enter Nucleai, his company that’s using AI to improve the science of “spatial biology,” which can ultimately unlock new treatments and cures…with cancer on their radar.

Avi and I get into how this all works, the staggering potential, and the real-world challenges that need to be overcome.

Nucleai

https://nucleai.ai

Merck’s $14 million investment in Nucleai:

https://www.businesswire.com/news/home/20240403580481/en/Merck’s-Corporate-Venture-M-Ventures-Arm-Backs-Nucleai-to-Advance-Its-First-in-class-Spatial-AI-Biomarker-in-Active-Clinical-Enrollment

Virtually everyone in the AI space and Hollywood can agree on one thing: the system is broken. There’s no clear way of how to handle AI in Hollywood — or virtually any creative field — which has led to confusion, frustration, anger, and lawsuits. No one seems to have a good solution.

Enter Story Protocol.

Story, co-founded by today’s guest Jason Zhao (formerly of Google Deep Mind), is working to build the infrastructure for IP and AI — a network or even a marketplace, of sorts. The tech is a mix of AI and blockchain, and they recently raised $54 million from the likes of a16z and Endeavor to try and pull this off.

Jason and I cover a LOT of ground. We get into the root causes of the problem, possible solutions, how Story Protocol works, and what are the challenges they need to overcome. (And along the way we might have created a Marvel and DC crossover.

Really fun episode.

Story Protocol:

https://www.storyprotocol.xyz

Variety’s story on Story Protocol:

https://variety.com/2023/digital/news/story-protocol-funding-endeavor-david-goyer-1235709843/

Jason’s presentation at the AI Summit at Consensus, which I was honored to host:

https://consensus2024.coindesk.com/agenda/event/-startups-vs-goliath-case-studies-227

As most people who have played with AI know, it can make stuff up, or what’s often referred to as “hallucinate.” (I like to think of it as “bullshitting.”

It’s one of the trickiest problems vexing the entire AI space. Why does AI do this? How widespread is the problem? What are the solutions, and is it even something that CAN be solved?

To unravel all this, we speak with Neil Katz, the founder of EyeLevel.AI, a company that’s developing solutions to help make AI more accurate (and less likely to hallucinate) for private companies. They're building what they call the "truth serum" for AI,

We dive deeeeep into the world of AI hallucinations, as it's one of the least understood--and most important--topics in the space.

I very much enjoyed.

Find Neil and EyeLevel.AI at:
https://www.eyelevel.ai/